TARSUS PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-1.4M | $2.4M |
| FY2019 | — | $-6.0M | $58.0M |
| FY2020 | — | $166.0M | $168.1M |
| FY2021 | $0 | $166.7M | $171.3M |
| FY2022 | $19.4M | $192.9M | $71.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-1.4M | $2.4M |
| FY2019 | — | $-6.0M | $58.0M |
| FY2020 | — | $166.0M | $168.1M |
| FY2021 | $0 | $166.7M | $171.3M |
| FY2022 | $19.4M | $192.9M | $71.7M |